TREA

97439484 - INDENA PHYTOSOME

Follow

Information

  • Trademark
  • 97439484
  • Serial Number
    97439484
  • Registration Number
    7251952
  • Filing Date
    June 02, 2022
    2 years ago
  • Registration Date
    December 26, 2023
    a year ago
  • Transaction Date
    December 26, 2023
    a year ago
  • Status Date
    December 26, 2023
    a year ago
  • Published for Opposition Date
    October 10, 2023
    a year ago
  • Location Date
    December 26, 2023
    a year ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    SWAIN, MICHELE LYNN
  • Attorney Docket Number
    037365
    Attorney Name
    Robert S. Broder
    Law Office Assigned Location Code
    M70
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
INDENA PHYTOSOME
Case File Statements
  • GS0401: Custom manufacture of pharmaceuticals by pharmaceutical compounders
  • GS0051: Pharmaceutical products for the treatment of cardiovascular system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, central nervous system diseases, chronic inflammatory diseases, skin diseases, urinary tract diseases, musculoskeletal disorders, metabolic diseases, ocular diseases, peripheral nervous disorders, ageing disorders, liver diseases, chronic fatigue syndrome; Pharmaceutical preparations and substances for the treatment of cardiovascular system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, central nervous system diseases, chronic inflammatory diseases, skin diseases, urinary tract diseases, musculoskeletal disorders, metabolic diseases, ocular diseases, peripheral nervous disorders, ageing disorders, liver diseases, chronic fatigue syndrome; Dietary and nutritional supplements; Plant and herb extracts for medicinal and pharmaceutical purposes and for the manufacture of dietary and nutritional supplements
  • GS0031: Cosmetics
  • GS0011: Active chemical ingredients for use in the manufacture of pharmaceuticals for the treatment of cardiovascular system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, central nervous system diseases, chronic inflammatory diseases, skin diseases, urinary tract diseases, musculoskeletal disorders, metabolic diseases, ocular diseases, peripheral nervous disorders, ageing disorders, liver diseases, chronic fatigue syndrome; Active chemical ingredients for use in the manufacture of nutritional supplements and dietetic preparations; Chemicals for use in the manufacture of pharmaceuticals, nutritional supplements and dietetic preparations
Case File Event Statements
  • 12/26/2023 - a year ago
    16 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 12/26/2023 - a year ago
    15 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 10/10/2023 - a year ago
    14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 10/10/2023 - a year ago
    13 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 9/20/2023 - a year ago
    12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 9/1/2023 - a year ago
    11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 8/8/2023 - a year ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/8/2023 - a year ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/8/2023 - a year ago
    8 - ASSIGNED TO LIE Type: ALIE
  • 3/29/2023 - a year ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/21/2023 - a year ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/21/2023 - a year ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/21/2023 - a year ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/17/2023 - a year ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/9/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 6/6/2022 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP